Simultaneous monitoring of levodopa, dopamine and their metabolites in skeletal muscle and subcutaneous tissue in different pharmacological conditions using microdialysis
- 1 July 1993
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 11 (7) , 577-585
- https://doi.org/10.1016/0731-7085(93)80008-o
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- LevodopaThe Lancet, 1992
- In vivo pharmacokinetics of levodopa and 3-O-methyldopa in muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1991
- Reduction of Circulating 3-O-Methyldopa by Inhibition of Gatechol-O-Methyltransferase With OR-611 and OR-462 in Cynomolgus MonkeysClinical Neuropharmacology, 1991
- Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopaEuropean Journal of Clinical Pharmacology, 1991
- Effect of Nitecapone (OR-462) on the Pharmacokinetics of Levodopa and 3-O-Methyldopa Formation in Cynomolgus MonkeysClinical Neuropharmacology, 1990
- Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the ratEuropean Journal of Pharmacology, 1988
- Clinical Pharmacokinetics of Anti-Parkinsonian DrugsClinical Pharmacokinetics, 1987
- 3‐O‐Methyldopa and the response to levodopa in Parkinson's diseaseAnnals of Neurology, 1987
- 3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- The metabolism of L‐3–0‐methyldopa, aprecursor of dopa in manClinical Pharmacology & Therapeutics, 1971